Home > Medical cannabis in the UK.

Stevens, Alex [BMJ] . (2018) Medical cannabis in the UK. BMJ, 363 (k4844) doi: https://doi.org/10.1136/bmj.k4844

URL: https://www.bmj.com/content/363/bmj.k4844

Patients should not be criminalised for seeking benefits:
Do patients have the right to medicate themselves, or should they be punished for doing so? Should their doctors work with them to decide on the best treatment, or does the government know best? These questions are at the heart of the current debate on the use of cannabis as medicine.

In the UK, “cannabis based products for medical use in humans” were rescheduled on 1 November 2018. They were placed in schedule 2 of the Misuse of Drugs Regulations, alongside several opioid analgesics. In theory, this means they can now be prescribed. In practice, the NHS has warned that “very few people in England are likely to get a prescription for medical cannabis,” because of the tight restrictions that have been put in place....


Item Type:Evidence resource
Publication Type:Report
Drug Type:Cannabis
Intervention Type:AOD disorder, AOD disorder harm reduction
Source:BMJ
Date:16 November 2018
Volume:363
Number:k4844
EndNote:View
Subjects:B Substances > Cannabis product (synthetic cannabinoids)
E Concepts in biomedical areas > Substance by legal status > Prescription drug (medicine / medication)
G Health and disease > State of health
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page